{"data":{"id":"us-dc/d.c.-code-44-109.02","jurisdiction":"us-dc","citation":"D.C. Code § 44-109.02","heading":"Pre-admission medication management assessment.","body":"Within 30 days prior to admission, the ALR shall consult with the prospective resident’s healthcare practitioner regarding:\n\n(1)\nThe prospective resident’s current medication profile, including a review  of nonprescription drugs;\n\n(2)\nPossible adverse interactions;\n\n(3)\nCommon expected or unexpected side effects; and\n\n(4)\nThe potential that such medications have to act as chemical restraints.","path":["Title 44. Charitable and Curative Institutions.","Chapter 1. Assisted Living Residence Regulation.","Subchapter IX. Medication Management."],"source_url":"https://code.dccouncil.gov/us/dc/council/code/sections/44-109.02","current_through":"2026-08-20 (D.C. Law 26-175)","vintage":"","retrieved_at":"2026-08-29T05:44:07Z","sha256":"35cdad9d02c4fbf12af0dc0967bc46b926de157a7149805cd3d832465a58228c","source_id":"us-dc","stale":false,"prev":"us-dc/d.c.-code-44-109.01","next":"us-dc/d.c.-code-44-109.03"},"notice":"GroundRules: Original legal text. Not legal advice."}